Latest Regulatory News

ECS Botanics has delivered a fifth consecutive quarter of positive operating cash flow, while branded sales and international expansion continue to reshape the business. The next test is whether planned UK and Polish launches can convert into recurring revenue.

Algorae has secured exclusive Australian commercial rights across eight Umedica-branded molecules while separately advancing a Umedica-supplied product towards regulatory approval. The broader arrangement remains partly non-binding, with financial terms undisclosed and TGA approval still pending.

Cryosite delivered record first-quarter results, with revenue up 17% to $4.6 million and EBITDA rising 31% to $1.3 million. The more consequential test now sits with the TGA, which has audited the company’s Auburn facility as part of a potential licence expansion.

AdAlta expects an additional R&D Tax Incentive refund of more than A$1 million after securing approval for specified overseas work on its EW-001 CAR-T therapy. The cash benefit arrives as the company prepares for a US FDA pre-IND meeting in November.

Medallion Metals is moving towards first gold production, with Cosmic Boy processing scheduled to begin this month and initial sales expected in November. At Kundip, the first box-cut blast is complete and underground development remains targeted for December.

Jade Gas has begun drilling Mongolia’s first multilateral coal bed methane well at Red Lake, testing a five-branch design intended to improve future production. The milestone arrives as negotiations for a proposed US$762.5 million Phase 1 development advance, but binding agreements are now targeted for November.

South32 has maintained FY27 production guidance across every operation, while Sierra Gorda delivered stronger copper output and Hermosa cleared a major permitting hurdle. The quarter also exposed a sharp Cannington setback, with zinc-equivalent production falling 27% as paste backfill constraints disrupted mining.

FleetPartners has agreed to a $1.131 billion cash takeover by SG Fleet after a competitive auction lifted the offer to $5.30 per share. The deal still requires shareholder, court and regulatory approval, with completion targeted for March 2027.

New Hope has agreed to acquire the Malabar shares it does not already own in an all-scrip deal valuing Malabar at about A$1.8 billion. The transaction would give New Hope full control of the ramping Maxwell underground mine and create a coal group targeting roughly 19Mtpa of saleable production.

Ampol's third-quarter trading strengthened as Lytton refinery margins more than doubled and Convenience Retail sales surged, but extra maintenance will reduce expected fourth-quarter higher-value product output by about 150 million litres. The Ultra Low Sulfur Fuels project has also slipped into the first quarter of 2027, while the proposed Evie Networks acquisition awaits regulatory clearance.

Reliance Worldwide Corporation’s go-shop period has ended without an alternative proposal, leaving Brookfield’s US$3.38-per-share takeover as the only deal before shareholders. The board has reaffirmed its unanimous recommendation, but the scheme still requires shareholder, Court, regulatory and expert approval.

Buru Energy has applied for a Production Licence covering its wholly owned Rafael gas and condensate field in Western Australia, moving the project into another key regulatory phase. The application follows the booking of 15.25 MMboe of 2P Reserves and keeps planned 2027 drilling and early 2029 first gas in view, subject to approvals and funding.